Agenus Inc. (AGEN)
NASDAQ·Healthcare·Biotechnology
$2.96
-0.67%
Mkt Cap $134.09M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$7.33
Range $7.00 – $8.00
Implied Upside
+147.6%
Consensus $7.33 vs current $2.96
NASDAQ·Healthcare·Biotechnology
$2.96
-0.67%
Mkt Cap $134.09M
No recent rating data.
Price Target (5 analysts)
$7.33
Range $7.00 – $8.00
+147.6%
Consensus $7.33 vs current $2.96